Company news
Synmosa Biopharma Corp news
Latest news releases, newest first.
Synmosa Biopharma To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer
August 11, 2022
The Company's 2022 Second quarter consolidated financial statements have been reported to the Board
August 11, 2022
Announcement of the Company's adjustment of the number for the transfer treasury shares to employees through the resolution of the board of directors on 7/29
August 2, 2022
Announcement of the Company's board of directors resolution on transfer treasury shares to employees and the record date of share subscription
July 29, 2022
Synmosa Biopharma announces the record date for 2021 dividend through retained earning.
June 22, 2022
Announcement by Synmosa to dispose Real property. (Update sale profit and loss)
June 17, 2022
Announcement the re-election of Directors (Including Independent Directors) of the Company
May 25, 2022
Announcement of the election of the chairman of the board of directors of the company
May 25, 2022
2022 Shareholders' Meeting Major Resolutions Shareholders' Meeting
May 25, 2022
2022 Shareholders' Meeting approved the “lifting of non-competition restrictions on newly appointed directors and their representatives”case.
May 25, 2022
Announcement of change in the Company's accounting officer and financial officer
March 29, 2022
Board of Directors resolved to buy back common stocks
March 29, 2022
The Board of Synmosa resolves to increase capital stock by earnings recapitalization
March 29, 2022
Board of Directors approved dividend distribution
March 29, 2022
The Company's 2021 consolidated financial statements have been reported to the Board
March 29, 2022
Board of Directors resolved to convene the 2022 Annual Shareholders' Meeting
March 29, 2022